Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Regorafenib> ?p ?o }
- Regorafenib abstract "Regorafenib (BAY 73-4506, commercial name Stivarga) is an oral multi-kinase inhibitor developed by Bayer which targets angiogenic, stromal and oncogenic receptor tyrosine kinase (RTK). Regorafenib shows anti-angiogenic activity due to its dual targeted VEGFR2-TIE2 tyrosine kinase inhibition. Since 2009 it was studied as a potential treatment option in multiple tumor types. By 2015 it had 2 US approvals for advanced cancers.".
- Regorafenib atcPrefix "L01".
- Regorafenib atcSuffix "XE21".
- Regorafenib bioavailability "69.0".
- Regorafenib casNumber "755037-03-7".
- Regorafenib chEBI "68647".
- Regorafenib iupacName "4-[4-({[4-Chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide hydrate".
- Regorafenib pubchem "11167602".
- Regorafenib thumbnail Regorafenib.svg?width=300.
- Regorafenib wikiPageID "24395425".
- Regorafenib wikiPageLength "7833".
- Regorafenib wikiPageOutDegree "20".
- Regorafenib wikiPageRevisionID "708075294".
- Regorafenib wikiPageWikiLink Angiogenesis.
- Regorafenib wikiPageWikiLink Bayer.
- Regorafenib wikiPageWikiLink Cancer_Drugs_Fund.
- Regorafenib wikiPageWikiLink Category:Pyridines.
- Regorafenib wikiPageWikiLink Category:Receptor_tyrosine_kinase_inhibitors.
- Regorafenib wikiPageWikiLink Category:Ureas.
- Regorafenib wikiPageWikiLink Chemotherapy-induced_acral_erythema.
- Regorafenib wikiPageWikiLink Colorectal_cancer.
- Regorafenib wikiPageWikiLink Cytochrome_P450.
- Regorafenib wikiPageWikiLink Epoxide_hydrolase_2.
- Regorafenib wikiPageWikiLink Epoxydocosapentaenoic_acid.
- Regorafenib wikiPageWikiLink Epoxyeicosatrienoic_acid.
- Regorafenib wikiPageWikiLink Epoxygenase.
- Regorafenib wikiPageWikiLink Food_and_Drug_Administration.
- Regorafenib wikiPageWikiLink Gastrointestinal_stromal_tumor.
- Regorafenib wikiPageWikiLink Omega-3_fatty_acid.
- Regorafenib wikiPageWikiLink Pre-clinical_development.
- Regorafenib wikiPageWikiLink Receptor_tyrosine_kinase.
- Regorafenib wikiPageWikiLink UGT1A9.
- Regorafenib wikiPageWikiLink VEGF_receptors.
- Regorafenib wikiPageWikiLinkText "Regorafenib".
- Regorafenib wikiPageWikiLinkText "regorafenib".
- Regorafenib atcPrefix "L01".
- Regorafenib atcSuffix "XE21".
- Regorafenib bioavailability "69".
- Regorafenib c "21".
- Regorafenib casNumber "755037".
- Regorafenib chebi "68647".
- Regorafenib chembl "1946170".
- Regorafenib chemspiderid "28295228".
- Regorafenib cl "1".
- Regorafenib eliminationHalfLife "-108000.0".
- Regorafenib excretion "Faeces , urine".
- Regorafenib f "4".
- Regorafenib h "17".
- Regorafenib inchi "1".
- Regorafenib inchikey "ZOPOQLDXFHBOIH-UHFFFAOYAO".
- Regorafenib iupacName "4".
- Regorafenib kegg "D10138".
- Regorafenib legalAu "S4".
- Regorafenib legalCa "Rx-only".
- Regorafenib legalUk "POM".
- Regorafenib legalUs "Rx-only".
- Regorafenib metabolism "Hepatic".
- Regorafenib molecularWeight "482.82".
- Regorafenib n "4".
- Regorafenib o "4".
- Regorafenib pregnancyAu "D".
- Regorafenib pregnancyUs "D".
- Regorafenib proteinBound "99.5".
- Regorafenib pubchem "11167602".
- Regorafenib routesOfAdministration "Oral".
- Regorafenib smiles "CNCc1ccOc2cccNCNc3cccCl.O".
- Regorafenib stdinchi "1".
- Regorafenib stdinchikey "ZOPOQLDXFHBOIH-UHFFFAOYSA-N".
- Regorafenib synonyms "BAY 73-4506".
- Regorafenib tradename "Stivarga".
- Regorafenib wikiPageUsesTemplate Template:Drugbox.
- Regorafenib wikiPageUsesTemplate Template:Ebicite.
- Regorafenib wikiPageUsesTemplate Template:Extracellular_chemotherapeutic_agents.
- Regorafenib wikiPageUsesTemplate Template:Reflist.
- Regorafenib subject Category:Pyridines.
- Regorafenib subject Category:Receptor_tyrosine_kinase_inhibitors.
- Regorafenib subject Category:Ureas.
- Regorafenib hypernym Inhibitor.
- Regorafenib type ChemicalSubstance.
- Regorafenib type Drug.
- Regorafenib type Heterocycle.
- Regorafenib type Inhibitor.
- Regorafenib type Redirect.
- Regorafenib type ChemicalObject.
- Regorafenib type Thing.
- Regorafenib type Q8386.
- Regorafenib comment "Regorafenib (BAY 73-4506, commercial name Stivarga) is an oral multi-kinase inhibitor developed by Bayer which targets angiogenic, stromal and oncogenic receptor tyrosine kinase (RTK). Regorafenib shows anti-angiogenic activity due to its dual targeted VEGFR2-TIE2 tyrosine kinase inhibition. Since 2009 it was studied as a potential treatment option in multiple tumor types. By 2015 it had 2 US approvals for advanced cancers.".
- Regorafenib label "Regorafenib".
- Regorafenib sameAs Q3891664.
- Regorafenib sameAs Regorafenib.
- Regorafenib sameAs Regorafeniib.
- Regorafenib sameAs Régorafénib.
- Regorafenib sameAs רגורפניב.
- Regorafenib sameAs レゴラフェニブ.
- Regorafenib sameAs Regorafenibas.
- Regorafenib sameAs m.07s3mjs.
- Regorafenib sameAs Регорафениб.
- Regorafenib sameAs Regorafenib.
- Regorafenib sameAs Regorafenib.
- Regorafenib sameAs Q3891664.